Differentiating respiratory syncytial virus pneumonia from interstitial lung disease associated with systemic sclerosis: A case report
Authors:
- Hiroki WakabayashiHWHiroki Wakabayashi
- Kaichi KanekoKKKaichi Kaneko
- Eisuke TanakaETEisuke Tanaka
- Ryogo OhashiRORyogo Ohashi
- Kensuke NambaKNKensuke Namba
- Misa IwayanagiMIMisa Iwayanagi
- Hiromasa SakuraiHSHiromasa Sakurai
- Yusuke IrieYIYusuke Irie
- Daiki SakaiDSDaiki Sakai
- Kenta TakashimaKTKenta Takashima
- Yu MurakamiYMYu Murakami
- Ai NishidaANAi Nishida
Open Access
- 14 November 2025
- journal article
- case report
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (46) , e45924
Abstract
Rationale: Respiratory syncytial virus (RSV) is a common cause of lower respiratory tract infections in older adults. In systemic sclerosis, interstitial lung disease is a frequent, serious complication requiring immunosuppressive therapy. Differentiating RSV pneumonia from systemic sclerosis-associated interstitial lung disease (SSc-ILD) is essential for appropriate management and to avoid initiating immunosuppressive agents that may be harmful in cases of RSV pneumonia. Patient concerns: An 85-year-old woman with limited cutaneous systemic sclerosis and dementia presented with a 1-week history of nonproductive cough and fever. Diagnoses: Chest computed tomography (CT) showed bilateral consolidations, bronchial wall thickening, and mucus plugs, suggesting airway infection. However, both respiratory symptoms and CT findings worsened, and sputum and blood cultures remained negative. To differentiate SSc-ILD from viral infection, multiplex PCR testing (FilmArray) of a pharyngeal swab was performed, detecting RSV and confirming RSV pneumonia. Interventions: The patient was initially treated with intravenous ceftriaxone, then given prednisolone at 0.6 mg/kg/d after RSV was diagnosed. Outcomes: Her respiratory symptoms and CT findings improved, and she was discharged on day 16 with tapering corticosteroids. Lessons: Multiplex PCR is useful for detecting RSV pneumonia in patients with autoimmune diseases. Clinicians should be aware that RSV infection can occur in these patients and should consider RSV pneumonia as an important differential diagnosis of SSc-ILD.Keywords
This publication has 11 references indexed in Scilit:
- Patient characteristics and pharmacologic treatment patterns in antifibrotic-treated patients with fibrosing interstitial lung diseases: real-world results from a claims databaseBMC Pulmonary Medicine, 2025
- High mortality of patients with severe pneumonia caused by respiratory syncytial virus, August 2021–June 2023, TaiwanJournal of Microbiology, Immunology and Infection, 2023
- Respiratory Syncytial Virus: A Systematic Review and Meta-Analysis of Tomographic Findings (2000–2022)Children, 2023
- Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge StudyNew England Journal of Medicine, 2022
- Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic SclerosisCurrent Rheumatology Reports, 2022
- Interstitial Lung Disease in Systemic Sclerosis: Focus on Early Detection and InterventionOpen Access Rheumatology: Research and Reviews, 2019
- Multicenter Evaluation of BioFire FilmArray Respiratory Panel 2 for Detection of Viruses and Bacteria in Nasopharyngeal Swab SamplesJournal of Clinical Microbiology, 2018
- Systemic sclerosisThe Lancet, 2017
- Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and TreatmentClinical Microbiology Reviews, 2017
- The Effect of Steroid Use in Hospitalized Adults With Respiratory Syncytial Virus-Related IllnessChest, 2011